Methyl4-amino-5-(trifluoromethyl)pyridine-2-carboxylate, 98%, 500mg

3-Isopropoxy-4-methylaniline hydrochloride, 97.0%, 1g

(1R*,4R*)-4-(2-Aminophenylamino)cyclohexanol, 1g

(4aR,8aR)-Ethyl 7-oxooctahydro-2H-pyrano[3,2-c]pyridine-4a-carboxylate, 95%, 250mg

5-Nitro-2-(piperidine-1-yl)pyridine, 95.0%, 5g

4-Butyl-3-thiosemicarbazide, 2.5g

2,5-Difluoro-4-nitrobenzoic acid, 97.0%, 10g

2,4-Thiazolidinedione, 5-[[4-[(3,4-dihydro-3-methyl-4-oxo-2-quinazolinyl)methoxy]phenyl]methyl]-, 98%, 10mg

N-[(1R,2R)-2-Amino-1,2-bis(4-methoxyphenyl)ethyl]4-methylbenzenesulfonamide, 97%, 5g

Solution standard ICP de tungstène, ROTI®Star, 10000 mg/l W, densité (D) 1 g/cm³

6,7-Difluoro-1H-indazole, 95.0%, 250mg

Primidone>98.0%(HPLC)(N)25g

SCOPOLIN, 95%, 10mg